The Numbers That Make Investors Pay Attention

Your best budtender just sold $800 in thirty minutes. Your regulars bring their friends. Last month’s numbers looked solid.

But when you talk to investors or banks, they squint at your pitch deck like you’re speaking a different language.

Here’s what’s actually happening: they’re not judging your dispensary. They’re looking for proof that what’s working today will still work six months from now. And most owners show them the wrong proof.

Why investors don’t buy potential — they buy proof

Investors see a hundred pitches. Half of them say “we’re growing fast” with screenshots of one good weekend. The other half talk about their vibe, their community connection, their Instagram following.

None of that matters if it doesn’t repeat.

What separates funded dispensaries from passed-over ones isn’t size or location. It’s predictable performance. A $500K-per-month dispensary with a 40% repeat purchase rate is more fundable than a $1M-per-month dispensary with 15% repeat rate. Investors aren’t buying your revenue — they’re buying your repeatability.

They want to see that customers don’t just buy once — they come back. That your margins don’t swing wildly month to month. That your growth isn’t just luck or one viral moment.

They’re not buying your story. They’re buying your pattern.

The five numbers that make investors lean in

Real investment conversations don’t start with “tell me about your brand.” They start with “show me your repeat purchase rate.”

Here’s what actually moves the needle:

Repeat purchase rate — the percentage of customers who come back. If 30-40% of your buyers return within 90 days, you’re not just making sales. You’re building loyalty investors can count on. And here’s what most owners miss: high repeat rates mean your customer acquisition cost drops over time. Every marketing dollar works harder as your business matures. Investors see that as a moat that deepens automatically.

Customer lifetime value (CLV) — how much a customer spends with you over time, not just once. A $50 first purchase means nothing. A customer who comes back eight times and spends $400 total? That’s a relationship worth financing.

Average order value (AOV) — what each transaction is worth. If your AOV climbs quarter over quarter, it means your team is getting better at recommending products people actually want. Investors see that as operational maturity. But here’s the tension: you can push AOV today through aggressive upselling and hurt your repeat rate next quarter. Investors want both trending up, which forces you to balance short-term wins against long-term loyalty.

Profit margin stability — consistent margins prove you’re not just discounting your way to volume. Wild swings signal chaos. Steady 20-25% margins signal control. Anyone can buy revenue with discounts — remember Groupon? Investors loved their customer acquisition numbers until they realized those customers never came back at full price. Dispensaries running constant promotions risk the same collapse. Repeat purchases at stable margins would’ve revealed the problem early.

Review growth rate — how fast you’re earning new Google reviews. Ten percent month-over-month growth isn’t vanity. Investors see review velocity the same way lenders see payment history: proof of reliable performance. It’s measurable community trust turning into business equity.

These aren’t marketing metrics. They’re financial health signals dressed in customer behavior. And here’s what makes them powerful: they’re leading indicators. Revenue and profit tell you what already happened. Repeat rates, review growth, and AOV trends predict what’s coming. Watch these to avoid margin compression and cash flow problems before they show up in your P&L.

How to track these without fancy tools

You don’t need a $10K analytics platform or an expensive consultant to package this data. Your POS already has most of it. The breakthrough isn’t new technology — it’s recognizing that your point-of-sale system already contains investor-grade intelligence. You just need to know what to extract.

Pull a 90-day customer report. Count how many customers made 2+ purchases. Divide by total customers. That’s your repeat rate.

Export order history to Google Sheets. Average out the transaction values. Track if that number goes up each month. That’s your AOV trend.

Check your Google Business Profile monthly. Count new reviews. Compare to last month. That’s your review growth rate.

CLV takes a little more work — track a cohort of customers from their first purchase forward and add up what they spend over six months. But even a rough estimate beats nothing.

You’re not building a data science lab. You’re proving patterns.

What good numbers look like

Here’s where most owners get stuck: they compare themselves to industry benchmarks from markets they’re not in and feel defeated.

Forget that. Compare against your own baseline. If your repeat rate was 22% last quarter and it’s 28% now, that momentum matters more to investors than knowing some national average is 31%. You’re in rural Oregon — they’re averaging dispensaries in downtown LA. Different game entirely.

If 30-40% of your customers return, you’re doing better than most local retailers in any category. If your AOV grows 5-10% quarter over quarter, your upsell system is working. If you’re adding 8-12 reviews a month and that number’s climbing, your community trusts you.

The magic isn’t hitting some perfect number. It’s showing improvement. Investors fund momentum, not perfection.

And here’s the thing these metrics actually prove: the intangible stuff you’ve built. Your budtender’s personal touch shows up as repeat rates. Your community vibe shows up as review growth. The metrics don’t replace your culture — they prove it’s working. You don’t have to choose between staying authentic and becoming fundable. The numbers translate what makes you special into language investors understand.

Turn marketing results into investor confidence

Every returning customer is revenue insurance. Every five-star review is third-party validation. Every local ranking improvement is free customer acquisition that compounds.

When you tell an investor “we rank #1 for cannabis delivery in our city,” you’re not bragging. You’re explaining why customer acquisition costs stay low while competitors burn cash on ads.

When you show them your repeat purchase rate climbing, you’re proving retention — which means every new customer is worth more over time.

And when your banker asks about Schedule III reclassification uncertainty or federal regulatory risk, you show them 38% repeat rates sustained over 18 months. The data doesn’t eliminate regulatory volatility, but it proves your specific business works regardless of the policy noise.

Marketing data isn’t fluff. It’s the evidence your business model works without you having to pay for every single customer forever.

Here’s how to present it: one metric is an anecdote. Two correlated metrics — rising AOV plus stable margins — suggest a system. Five metrics trending positively over multiple quarters? That’s an investable pattern. Investors use pattern recognition to filter signal from noise. Give them the full picture.

Package these five metrics into one slide. Show the trend lines. Let the numbers tell the story your passion can’t.

Investors don’t need to love cannabis. They need to love patterns that print money.

Next step — prove that your marketing builds real equity

These numbers don’t just help you raise money. They increase what your dispensary is actually worth when it’s time to sell or expand. That’s the part most owners miss — and the next conversation we need to have.